J&J and distributors settle opioid action for $26bn
Sarah JollyJuly 22, 2021
Four US pharmaceutical companies have agreed a $26bn payment to settle almost 4,000 claims that they have driven an opioid addiction crisis in the country.
Brokered by a group of state attorney generals but awaiting approv...
Want to read this article?
Register for ultimate access to this article and ALL our premium content
ULTIMATE ACCESS PROVIDES YOU WITH
- Unrestricted access to Commercial Risk, Commercial Risk Europe and Global Risk Manager news, exclusive expert analysis and opinion
- Breaking news, daily and/or weekly Commercial Risk Europe newsletters and regular digital publications
- Breaking news, weekly and monthly Global Risk Manager newsletters and quarterly digital Journal
- European and global surveys, rankings and special reports
- National European local language newsletters
- Preferential access to webinars and virtual and physical conferences
If you are already a registered user or subscriber you can LOGIN below for ultimate access:
Sarah JollyJuly 22, 2021